The burden of liver diseases is substantial, demanding groundbreaking therapeutic modalities. Cellular therapies represent a remarkably hopeful avenue, offering the potential to regenerate damaged parenchymal tissue and alleviate clinical outcomes. Currently, research focuses on several approaches, including the delivery of induced pluripotent cell